Literature DB >> 27330452

2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.

Dennis Dlugos1, Greg Worrell2, Kathryn Davis3, William Stacey4, Jerzy Szaflarski5, Andres Kanner6, Sridhar Sunderam7, Mike Rogawski8, Patrice Jackson-Ayotunde9, Tobias Loddenkemper10, Beate Diehl11, Brandy Fureman12, Ray Dingledine13.   

Abstract

Entities:  

Year:  2016        PMID: 27330452      PMCID: PMC4913858          DOI: 10.5698/1535-7511-16.3.192

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  51 in total

1.  Temperatures achieved in human and canine neocortex during intraoperative passive or active focal cooling.

Authors:  Matthew D Smyth; Rowland H Han; Chester K Yarbrough; Edward E Patterson; Xiao-Feng Yang; John W Miller; Steven M Rothman; Raimondo D'Ambrosio
Journal:  Ther Hypothermia Temp Manag       Date:  2015-04-22       Impact factor: 1.286

2.  Slow Spatial Recruitment of Neocortex during Secondarily Generalized Seizures and Its Relation to Surgical Outcome.

Authors:  Louis-Emmanuel Martinet; Omar J Ahmed; Kyle Q Lepage; Sydney S Cash; Mark A Kramer
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

3.  Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy.

Authors:  Nagisa Sada; Suni Lee; Takashi Katsu; Takemi Otsuki; Tsuyoshi Inoue
Journal:  Science       Date:  2015-03-20       Impact factor: 47.728

4.  Managing information well: Toward an ontology-driven informatics platform for data sharing and secondary use in epilepsy self-management research centers.

Authors:  Satya S Sahoo; Guo-Qiang Zhang; Yvan Bamps; Robert Fraser; Shelley Stoll; Samden D Lhatoo; Curtis Tatsuoka; Johnny Sams; Elisabeth Welter; Martha Sajatovic
Journal:  Health Informatics J       Date:  2015-03-13       Impact factor: 2.681

5.  Mild passive focal cooling prevents epileptic seizures after head injury in rats.

Authors:  Raimondo D'Ambrosio; Clifford L Eastman; Felix Darvas; Jason S Fender; Derek R Verley; Federico M Farin; Hui-Wen Wilkerson; Nancy R Temkin; John W Miller; Jeffrey Ojemann; Steven M Rothman; Matthew D Smyth
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

Review 6.  Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation.

Authors:  Raimondo D'Ambrosio; Clifford L Eastman; Cinzia Fattore; Emilio Perucca
Journal:  Expert Rev Neurother       Date:  2013-06       Impact factor: 4.618

7.  Memory fMRI predicts verbal memory decline after anterior temporal lobe resection.

Authors:  Meneka K Sidhu; Jason Stretton; Gavin P Winston; Mark Symms; Pamela J Thompson; Matthias J Koepp; John S Duncan
Journal:  Neurology       Date:  2015-03-13       Impact factor: 9.910

8.  Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy.

Authors:  Barry E Gidal; Antonio Laurenza; Ziad Hussein; Haichen Yang; Randi Fain; Jacob Edelstein; Dinesh Kumar; Jim Ferry
Journal:  Neurology       Date:  2015-04-15       Impact factor: 9.910

9.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.

Authors:  Scott C Baraban; Matthew T Dinday; Gabriela A Hortopan
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel.

Authors:  Alan B Ettinger; Antonia LoPresti; Haichen Yang; Betsy Williams; Sharon Zhou; Randi Fain; Antonio Laurenza
Journal:  Epilepsia       Date:  2015-07-03       Impact factor: 5.864

View more
  5 in total

Review 1.  Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.

Authors:  Melissa Barker-Haliski; H Steve White
Journal:  Neuropharmacology       Date:  2019-08-27       Impact factor: 5.250

2.  Chemical biomarkers of epileptogenesis and ictogenesis in experimental epilepsy.

Authors:  Hiram Luna-Munguia; Alexander G Zestos; Stephen V Gliske; Robert T Kennedy; William C Stacey
Journal:  Neurobiol Dis       Date:  2018-10-07       Impact factor: 5.996

3.  The 2021 Epilepsy Research Benchmarks-Respecting Core Principles, Reflecting Evolving Community Priorities.

Authors:  Eric D Marsh; Vicky Whittemore; Miriam Leenders; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2021-06-30       Impact factor: 7.500

4.  Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.

Authors:  Stephen F Traynelis; Dennis Dlugos; David Henshall; Heather C Mefford; Michael A Rogawski; Kevin J Staley; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-22       Impact factor: 7.500

5.  The Benchmarks: Progress and Emerging Priorities in Epilepsy Research.

Authors:  Annapurna Poduri; Vicky Holets Whittemore
Journal:  Epilepsy Curr       Date:  2019-12-23       Impact factor: 7.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.